MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
2.790
+0.160 (6.08%)
At close: Apr 28, 2026, 4:00 PM EDT
2.849
+0.058 (2.10%)
After-hours: Apr 28, 2026, 7:48 PM EDT
MannKind Employees
As of December 31, 2025, MannKind had 592 total employees, including 591 full-time and 1 part-time employees. The number of employees increased by 185 or 45.45% compared to the previous year.
Employees
592
Change (1Y)
185
Growth (1Y)
45.45%
Revenue / Employee
$589,470
Profits / Employee
$9,904
Market Cap
861.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 403 |
| Kura Oncology | 260 |
| ARS Pharmaceuticals | 163 |
| Cullinan Therapeutics | 109 |
| Theravance Biopharma | 90 |
| Alto Neuroscience | 68 |
| Crescent Biopharma | 44 |
| Bright Minds Biosciences | 26 |
MNKD News
- 6 weeks ago - MannKind Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - MannKind Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 - GlobeNewsWire
- 7 weeks ago - MannKind Announces Settlement of Convertible Senior Notes - GlobeNewsWire
- 7 weeks ago - MannKind to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - MannKind Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - MannKind Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire